HPR Dr. Schaffler GmbH
Human Pharmacodynamic Research
Skip to content
  • Home
  • Company
  • Services
  • Trial Participants/Volunteers
  • Contact
  • Legal notice
  • Privacy Policy
  • German
← Investigation of the predictive validity of laser- EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers
A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects →

A Randomized, Double-Blind, Placebo- and Active Comparator-Controlled Phase I Study of Analgesic/Antihyperalgesic Properties of ASP8477, a Fatty Acid Amide Hydrolase Inhibitor, in Healthy Female Subjects

Posted on December 20, 2017 by hprdsadmin

Klaus Schaffler, MD, Ashraf Yassen, PhD, PharmD, Peter Reeh, MD, PhD,
and Paul Passier, PhD

ASP8477 Paper_FAAH_LEP_Caps

Pain Medicine Dec 2017   DOI:10.1093/pm/pnx281

This entry was posted in Clinical Studies. Bookmark the permalink.
← Investigation of the predictive validity of laser- EPs in normal, UVB-inflamed and capsaicin-irritated skin with four analgesic compounds in healthy volunteers
A Phase I, randomized, double-blind, laser evoked potential study to evaluate the analgesic/anti-hyperalgesic effect of ASP9226, a state-dependent N-type voltage-gated calcium channel inhibitor, in healthy male subjects →
  • Questions?

    Contact us!
    Phone: +49-89-99322-0

HPR Dr. Schaffler GmbH
Proudly powered by WordPress.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Wir benutzen Cookies um die Darstellung unserer WebSite für Sie zu verbessern. Wenn Sie weiter unsere WebSite weiter benutzen, gehen wie davon aus, das Sie damit einverstanden sind.
OkMore / Mehr